Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Johnson & Johnson, a leader in immunology, has developed ARGES, a new AI-powered tool that could transform endoscopic ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solution ...
Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Oral sphingosine 1-phosphate (S1P) 1 and 5 receptor agonist Zeposia (ozanimod) achieved all its targets in the True North trial involving adults with moderate-to-severe ulcerative colitis ...
Shares of Bausch Health Companies Inc. BHC gained 2.36% after the company reported better-than-expected fourth-quarter ...
for induction treatment of moderate-to-severe ulcerative colitis (UC), with patients who failed on immunomodulators, anti-TNFα, vedolizumab or corticosteroids. The topline results indicate that ...
He was among those targeted by the investigation that consumed much of Bill Clinton’s presidency. But his conviction was ...
The NHS has issued a warning regarding the use of the widely-used painkiller, ibuprofen, advising individuals to seek an ...
Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that ...
Ibuprofen is used to effectively relieve pain, fever, and inflammation. However, its use can be dangerous for some people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback